HER2 is a highly alluring target antigen owing to its high abundance in brain tumors, its role in tumor progression, and the capacity of HER2-specific CAR T cells to eradicate both differentiated cells and cancer-initiating cells [96]. The gene discussed is ERBB2; the disease is cancer.